E2112: Randomized Phase III Trial of Endocrine Therapy Plus Entinostat or Placebo in Hormone Receptor-Positive Advanced Breast Cancer. A Trial of the ECOG-ACRIN Cancer Research Gro... von Connolly, Roisin M., Zhao, Fengmin, Miller, Kathy D., Lee, Min-Jung, Piekarz, Richard L., Smith, Karen L., Brown-Glaberman, Ursa A., Winn, Jennifer S., Faller, Bryan A., Onitilo, Adedayo A., Burkard, Mark E., Budd, George T., Levine, Ellis G., Royce, Melanie E., Kaufman, Peter A., Thomas, Alexandra, Trepel, Jane B., Wolff, Antonio C., Sparano, Joseph A.

Volltext

Treatment of pancreatic cancer with epidermal growth factor receptor-targeted therapy von Faller, Bryan A, Burtness, Barbara

Volltext

Alliance Foundation Trial 09: A Randomized, Multicenter, Phase 2 Trial Evaluating Two Sequences of Pembrolizumab and Standard Platinum-Based Chemotherapy in Patients With Metastati... von Hensing, Thomas A., Wang, Xiaofei, Stinchcombe, Thomas E., Gao, Junheng, Knopp, Michael V., Watson, Mark, Dudek, Arkadiusz Z., Graziano, Stephen L., Patel, Jyoti D., Faller, Bryan A., Dragnev, Konstantin H., Kozono, David, Vokes, Everett E.

Volltext

Continuous versus intermittent BRAF and MEK inhibition in patients with BRAF-mutated melanoma: a randomized phase 2 trial von Algazi, Alain P., Othus, Megan, Daud, Adil I., Lo, Roger S., Mehnert, Janice M., Truong, Thach-Giao, Conry, Robert, Kendra, Kari, Doolittle, Gary C., Clark, Joseph I., Messino, Michael J., Moore, Dennis F., Lao, Christopher, Faller, Bryan A., Govindarajan, Rangaswamy, Harker-Murray, Amy, Dreisbach, Luke, Moon, James, Grossmann, Kenneth F., Ribas, Antoni

Volltext

Safety and Efficacy of Vinorelbine in the Treatment of Non-Small Cell Lung Cancer von Faller, Bryan A., Pandit, Trailokya N.

Volltext

Prospective Correlation of Magnetic Resonance Tumor Regression Grade With Pathologic Outcomes in Total Neoadjuvant Therapy for Rectal Adenocarcinoma von Hall, William A, Li, Jiahe, You, Y Nancy, Gollub, Marc J, Grajo, Joseph R, Rosen, Mark, dePrisco, Greg, Yothers, Greg, Dorth, Jennifer A, Rahma, Osama E, Russell, Marcia M, Gross, Howard M, Jacobs, Samuel A, Faller, Bryan A, George, Sagila, Al Baghdadi, Tareq, Haddock, Michael G, Valicenti, Richard, Hong, Theodore S, George, Thomas J

Volltext

A randomized study of genetic education versus usual care in tumor profiling for advanced cancer in the ECOG‐ACRIN Cancer Research Group (EAQ152) von Bradbury, Angela R., Lee, Ju‐Whei, Gaieski, Jill Bennett, Li, Shuli, Gareen, Ilana F., Flaherty, Keith T., Herman, Benjamin A., Domchek, Susan M., DeMichele, Angela M., Maxwell, Kara N., Onitilo, Adedayo A., Virani, Shamsuddin, Park, SuJung, Faller, Bryan A., Grant, Stefan C., Ramaekers, Ryan C., Behrens, Robert J., Nambudiri, Gopakumar S., Carlos, Ruth C., Wagner, Lynne I.

Volltext

Phase II randomized study of maintenance atezolizumab (A) versus atezolizumab + talazoparib (AT) in patients with SLFN11 positive extensive stage small cell lung cancer. S1929 von Karim, Nagla Abdel, Miao, Jieling, Reckamp, Karen L., Gay, Carl M., Byers, Lauren A., Zhao, Ying-Qi, Redman, Mary W., Carrizosa, Daniel R., Wang, Wei-Lien, Petty, William J., Mehta, Kathan, Faller, Bryan A., Agamah, Edem S., Kasbari, Samer S., Malisetti, Rajini K., Kumar, Atul, Schallenkamp, John, Alluri, Krishna C., Gray, Jhanelle E., Kelly, Karen

Volltext

A Dose-finding Study Followed by a Phase II Randomized, Placebo-controlled Trial of Chemoradiotherapy With or Without Veliparib in Stage III Non–small-cell Lung Cancer: SWOG 1206 (... von Argiris, Athanassios, Miao, Jieling, Cristea, Mihaela C., Chen, Allen M., Sands, Jacob M., Decker, Roy H., Gettinger, Scott N., Daly, Megan E., Faller, Bryan A., Albain, Kathy S., Yanagihara, Ronald H., Garland, Linda L., Byers, Lauren A., Wang, Ding, Koczywas, Marianna, Redman, Mary W., Kelly, Karen, Gandara, David R.

Volltext

New-Onset Clubbing Associated with Lung Cancer von Faller, Bryan A., Atkinson, John P.

Volltext

Images in clinical medicine. New-onset clubbing associated with lung cancer von Faller, Bryan A, Atkinson, John P

Volltext

Cardiac tamponade or hemopericardium are not associated with bleeding risk factors in consecutive patients hospitalized with noniatrogenic, pericardial effusions von Faller, Bryan A., Zhang, Qin, Picus, Joel

Volltext

Therapy-Related Acute Myelogenous Leukemia With an 11q23/ MLL Translocation Following Adjuvant Cisplatin and Vinorelbine for Non–Small-Cell Lung Cancer von Faller, Bryan A, Robu, Valentin G, Borghaei, Hossein

Volltext

A Systematic Framework to Rapidly Obtain Data on Patients with Cancer and COVID-19: CCC19 Governance, Protocol, and Quality Assurance von Accordino, Melissa K., Ahluwalia, Manmeet S., Alimohamed, Saif I., Angevine, Anne H., Bardia, Aditya, Bekaii-Saab, Tanios S., Bernicker, Eric H., Bindal, Poorva, Bonnen, Mark, Bouchard, Gabrielle, Cabal, Angelo, Cabalona, Wilhelmina D., Chen, James L., Clark, Melanie J., Clement, Jessica M., Cook, Erin, Dailey, Mark E., Davis, Elizabeth J., Deeken, John F., Del Prete, Salvatore A., Desai, Aakash, Doroshow, Deborah B., Elias, Rawad, Elkrief, Arielle, Elshoury, Amro, Ferrario, Cristiano, Friese, Christopher R., Gainor, Justin, Gartrell, Benjamin A., Gill, David M., Giordano, Antonio, Glace, (Mary) Grace, Graber, Jerome J., Grover, Punita, Gupta, Shilpa, Hafez, Navid, Hawley, Jessica E., Hershman, Dawn L., Hoyo-Ulloa, Irma, Islam, Jessica Yasmine, Jhawar, Sachin R., Kelleher, Kaitlin, Kennecke, Hagen F., Kumar, Vaibhav, Loaiza-Bonilla, Arturo, LoRusso, Patricia, Low, Clarke A., Lyman, Gary H., Lynch, Ryan C., Madhavan, Subha, Mansoor, Abdul-Hai, Markham, Merry-Jennifer, Mashru, Sandeep H., Masters, Tyler, Mavromatis, Blanche H., Menendez, Alvaro G., Mesa, Ruben A., Mico, Vasil, Miller, Chaim, Mishra, Sanjay, Monahan, Ryan S., Mulcahy, Mary F., Nakayama, John M., Nizam, Amanda, Nuzzo, Pier Vitale, Ohri, Nitin, Owenby, Susie, Panagiotou, Orestis A., Park, Cathleen, Pennell, Nathan A., Peters, Solange, Puc, Matthew, Ravindranathan, Deepak, Reuben, Daniel Y., Revankar, Sanjay G., Reynolds, Kerry L., Rhodes, Terence D., Saif, M. Wasif, Schweizer, Michael T., Shah, Pankil K., Shah, Mansi R., Shaya, Justin A., Shyr, Yu, Smits, Melissa, Stratton, Jamie, Subbiah, Suki, Tachiki, Lisa, Topaloglu, Umit, Vega-Luna, Karen, Venepalli, Neeta K., Vikas, Praveen, Wall, Sarah, Williams, Nicole, Wood, William A., Xie, Zhuoer, Yeh, Albert C., Yu, Peter Paul, Zaman, Qamar Ul, Zhang, Tian, Zhou, Alice Y.

Volltext

Continuous versus intermittent BRAF and MEK inhibition in patients withBRAF-mutated melanoma: a randomized phase 2 trial von Algazi, Alain P., Othus, Megan, Daud, Adil, Lo, Roger S., Mehnert, Janice M., Thach-Giao Truong, Conry, Robert, Kendra, Kari, Doolittle, Gary C., Clark, Joseph, Messino, Michael J., Moore, Dennis F., Lao, Christopher, Faller, Bryan A., Govindarajan, Rangaswamy, Harker-Murray, Amy, Dreisbach, Luke, Moon, James, Grossmann, Kenneth F., Ribas, Antoni

Volltext

Overall survival from a phase II randomized study of ramucirumab plus pembrolizumab versus standard of care for advanced non–small cell lung cancer previously treated with immunoth... von Reckamp, Karen L., Redman, Mary Weber, Dragnev, Konstantin H., Villaruz, Liza C, Faller, Bryan A., Al Baghdadi, Tareq, Hines, Susan, Qian, Lu, Minichiello, Katherine, Gandara, David R., Kelly, Karen, Herbst, Roy S.

Volltext

SWOG S1929: Phase II randomized study of maintenance atezolizumab (A) versus atezolizumab + talazoparib (AT) in patients with SLFN11 positive extensive stage small cell lung cancer... von Abdel Karim, Nagla Fawzy, Miao, Jieling, Reckamp, Karen L., Gay, Carl Michael, Byers, Lauren Averett, Zhao, Yingqi, Redman, Mary Weber, Carrizosa, Daniel R., Wang, Wei-Lien, Petty, William J., Mehta, Kathan, Faller, Bryan A., Agamah, Edem S., Kasbari, Samer S., Malisetti, Rajini Katipamula, Kumar, Atul, Schallenkamp, John, Alluri, Krishna Chaitanya, Gray, Jhanelle Elaine, Kelly, Karen

Volltext

A phase II study of rucaparib in patients with high genomic LOH and/or BRCA 1/2 mutated stage IV non-small cell lung cancer (Lung-MAP Sub-Study, S1900A) von Riess, Jonathan W., Redman, Mary Weber, Wheatley-Price, Paul, Faller, Bryan A., Villaruz, Liza C., Corum, Larry R., Gowda, Aruna C., Srkalovic, Gordan, Osarogiagbon, Raymond U., Baumgart, Megan Ann, Qian, Lu, Minichiello, Katherine, Gandara, David R., Herbst, Roy S., Kelly, Karen

Volltext

Phase II randomized study of ramucirumab plus pembrolizumab versus standard of care for advanced non-small cell lung cancer previously treated with a checkpoint inhibitor: Toxicity... von Reckamp, Karen L., Redman, Mary Weber, Dragnev, Konstantin H., Villaruz, Liza C., Faller, Bryan A., Al Baghdadi, Tareq, Hines, Susan, Qian, Lu, Minichiello, Katherine, Gandara, David R., Herbst, Roy S., Kelly, Karen

Volltext

Abstract GS4-02: E2112: Randomized phase 3 trial of endocrine therapy plus entinostat/placebo in patients with hormone receptor-positive advanced breast cancer. A trial of the ECOG... von Connolly, Roisin M, Zhao, Fengmin, Miller, Kathy D, Lee, Min-Jung, Piekarz, Richard L, Smith, Karen L, Brown-Glaberman, Ursa, Winn, Jennifer S, Faller, Bryan A, Onitilo, Adedayo A, Burkard, Mark E, Budd, George T, Levine, Ellis G, Royce, Melanie E, Kaufman, Peter A, Thomas, Alexandra, Trepel, Jane B, Wolff, Antonio C, Sparano, Joseph A

Volltext